SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.660-2.4%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HardToFind who wrote (12808)8/10/2020 6:58:48 PM
From: old 'n cranky   of 12871
 
Interesting find.
According to the most recent inspection conducted by PCAOB in 2016, EisnerAmper had multiple audit deficiencies. The firm had insufficient audit procedures for revenues, inventories, and allowance and provision for chargeback
Fortunately NNVC doesn't have any of that stuff to audit.



Since 2007, NanoViricides has been consistently late in its annual 10-K and quarterly 10-Q filings with the SEC
They've been no more consistent about that than they have about anything else.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News